RECENT NEWS

Registrations are now underway for the NHS Providers Annual Conference and Exhibition, which offers insights and networking opportunities to help NHS staff excel in leadership roles. Every year, the event brings together over 800 senior leaders from NHS Trusts, system partners and key stakeholders.

New research by the Health Foundation provides the first robust causal evidence that NHS surgical hubs increase treatment volumes and reduce the length of time patients spend in hospital. By delivering more operations in a shorter time, they could speed up efforts to tackle waiting lists

The Patients Association, a leading independent charity campaigning for improvements in health and social care for patients, has announced the appointment of two new trustees, Professor Alf Collins and Tom Grinyer.

On the 5th and 6th of September this year, Queen Mary University of London’s School of Engineering and Materials Science will host the 16th BioMedEng conference, welcoming over 400 Biomedical engineers, researchers, clinical specialists, government and industry representatives.

A team of Korean researchers has made a breakthrough that will greatly enhance the efficiency of respiratory disease research, by creating artificial lungs.

The Dengue vaccine has an efficacy rate of over 50% in reducing disease cases, with lasting effects and a very good safety profile.

When COVID-19 booster vaccines are in short supply, prioritising the elderly over other age groups for booster vaccination results in the lowest loss of life.

New research presented at the ESC Congress 2024 in London shows that women in the menopause transition period show changes in their blood cholesterol profiles which could have an adverse impact on their cardiovascular health.

A new study has revealed important information about how a patient’s testosterone level can help protect them from severe COVID-19. Previous research involving Swansea University investigated how sex hormones are likely to be important determinants of COVID-19 severity.

​Action on Pre-eclampsia (APEC) has welcomed the Scottish Government’s announcement of dedicated funding for pre-eclampsia testing in every Health Board – helping to protect thousands of pregnant mothers and babies in Scotland. This means that, for the first time, expectant mothers in Scotland will soon have access to placental growth factor (PlGF) testing, a simple blood test to help diagnose pre-eclampsia that has been available in England since 2016.

Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries.

The UK Health Security Agency (UKHSA) is reminding all higher education and university students – freshers and returning students – to make sure they are up to date with their free NHS childhood and adolescent vaccines against meningitis, measles and HPV ahead of starting the new academic year.

Ambulance crews spend significant time diverting resources to 999 callouts in prisons that are cancelled or not a serious enough medical emergency, says a new report from HSSIB.

Clinical follow-up using virtual voice technology helped identify complications after transcatheter aortic valve implantation (TAVI) with a high degree of patient satisfaction, according to research presented at ESC Congress 2024.

An inspiring webinar, taking place on 5th September 2024, aims to shine a spotlight on the remarkable achievements of female founders, CEOs, and CTOs spearheading innovation in the fast-paced world of HealthTech.

New research, presented at this year’s ESC Congress 2024 in London, shows that performing echocardiograms remotely using a 5G cellular network has similar accuracy to those performed in person by cardiologists.

Alpha Laboratories has announced that it has entered into a strategic partnership with Clinical Design Technologies, to market and support the 'world's first digital closed urine testing system'.

Childhood obesity can contribute to the development of common immune-mediated skin diseases (IMSDs), such as alopecia areata, atopic dermatitis, and psoriasis, new research finds.

The World Health Organization (WHO) has launched a global Strategic Preparedness and Response Plan to stop outbreaks of human-to-human transmission of mpox through coordinated global, regional, and national efforts.

Scientists at the University of Nottingham are scaling up the development of a new Zika virus DNA vaccine thanks to a collaboration with specialist company, Touchlight, who will provide new technology to produce large quantities of the DNA vaccine at speed.